Guidelines make no firm recommendations about surveillance of arteriovenous grafts as several randomised trials (RCT) have not shown a clear benefit in patency. However a more thorough review of these RCT based on epidemiological principles reveals significant limitations. In particular a key weakness of these older studies is the interventions performed for venous stenosis detected that was largely angioplasty. However, the observational data of modern stent-grafts shows a clear benefit over angioplasty, and thus seems to suggest that a modern well considered RCT is now mandated.
LumsdenABMacDonaldMJKikeriD, et al. Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. J Vasc Surg1997; 26(3): 382–390.
2.
RamSJWorkJCalditoGC, et al. A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int2003; 64: 272–280.
3.
DemberLMHolmbergEFKaufmanJS. Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney Int2004; 66: 390–398.
4.
MoistLMChurchillDNHouseAA, et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol2003; 14: 2645–2653.
5.
RobbinMLOserRFLeeJY, et al. Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney Int2006; 69: 730–735.
6.
MalikJSlavikovaMSvobodovaJ, et al. Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney Int2005; 67(4): 1554–1558.
7.
SalmanLRizviAContrerasG, et al. A multicenter randomized clinical trial of hemodialysis access blood flow surveillance compared to standard of care: the Hemodialysis Access Surveillance Evaluation (HASE) study. Kidney Int Rep2020; 5: 1937–1944.
8.
WilsonJMJungnerYG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam1968; 65: 281–393.
9.
EuropeW. Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. Copenhagen: WHO Regional Office for Europe, 2020.
10.
SteeleRJ. Screening and surveillance-principles and practice. Br J Radiol2018; 91: 20180200.
MarmotMGAltmanDGCameronDA, et al. The benefits and harms of breast cancer screening: an independent review. Br J Cancer2013; 108: 2205–2240.
13.
FineJPGrayRJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc1999; 94: 496–509.
14.
VerduijnMGrootendorstDCDekkerFW, et al. The analysis of competing events like cause-specific mortality: beware of the Kaplan-Meier method. Nephrol Dial Transplant2011; 26: 56–61.
15.
MillerDCDunnRLWeiJT. Assessing the performance and validity of diagnostic tests and screening. Totowa, NJ: Humana Press, 2006.
16.
DossabhoyNRRamSJNassarR, et al. Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care. Semin Dial2005; 18: 550–557.
17.
MartinLGMacDonaldMJKikeriD, et al. Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study. J Vasc Interv Radiol1999; 10: 389–396.
18.
MalikJ. Ultrasonography and graft patency. Kidney Int2006; 70: 1375–1376.
19.
KingsmoreDBStevensonKSThomsonPC, et al. Pre-emptive or reactive treatment, angioplasty or stent-graft? The outcome for interventions for venous stenosis in early-cannulation arteriovenous grafts. J Vasc Access. Epub ahead of print 2021. DOI: 10.1177/11297298211029413.
20.
KudlickaJMalikJTukaV, et al. Arteriovenous grafts: early ultrasonography tells their fortune. Am J Nephrol2015; 41: 420–425.
21.
KavanJKudlickaJMalikJ, et al. Treatment of failing arterio-venous dialysis graft by angioplasty, stent, and stent graft: two-years analysis of patency rates and cost-effectiveness. Exp Ther Med2019; 18: 4144–4150.
22.
HoareDBussooaANealeS, et al. The future of cardiovascular stents: bioresorbable and integrated biosensor technology. Adv Sci2019; 6: 1900856.
23.
BussooaANealeSMercerJR. Future of smart cardiovascular implants. Sensors2018; 18.
